Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.14 is 19% below its 5-year average of 2.63, near the low end of its 5-year range (2.13–3.44).
As of the fiscal period ended Tuesday, June 30, 2026. 15.49% below its 12-month average of 2.53.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.14.
CURRENT RATIO
2.14
CURRENT RATIO AVG TTM
2.53
CURRENT RATIO AVG 3Y
2.76
CURRENT RATIO AVG 5Y
2.63
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.49%
CURRENT VS 3Y AVG
-22.52%
CURRENT VS 5Y AVG
-18.69%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-43.17%
vs the sector median at left
Market Cap
$2.02B
Current Ratio
2.32
TTM Avg
2.34
3Y Avg
3.23
5Y Avg
3.57
Market Cap
$2.02B
Current Ratio
5.42
TTM Avg
4.91
3Y Avg
6.23
5Y Avg
8.44
Market Cap
$2.06B
Current Ratio
11.82
TTM Avg
14.70
3Y Avg
15.08
5Y Avg
16.52
Market Cap
$2.06B
Current Ratio
16.95
TTM Avg
14.04
3Y Avg
14.77
5Y Avg
14.32
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Progyny, Inc. (PGNY) | $2.03B | 2.14 | 2.53 | 2.76 | 2.63 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | 2.32 | 2.34 | 3.23 | 3.57 |
| UroGen Pharma Ltd. (URGN)vs › | $2.02B | 3.80 | 5.01 | 5.21 | 5.22 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 5.42 | 4.91 | 6.23 | 8.44 |
| Vericel Corporation (VCEL)vs › | $2.05B | 5.04 | 4.63 | 4.69 | 5.05 |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | 11.82 | 14.70 | 15.08 | 16.52 |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | 16.95 | 14.04 | 14.77 | 14.32 |
| Alvotech (ALVO)vs › | $2.08B | 1.65 | 2.12 | 1.59 | 1.52 |
| Fortrea Holdings Inc. (FTRE)vs › | $1.98B | 0.96 | 0.99 | 1.34 | 1.34 |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.97B | 8.55 | 6.61 | 7.37 | 8.17 |
Current Ratio
2.14
Quick Ratio
2.14
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.14 |
| 2026-03-31 | 2.13 |
| 2025-12-31 | 2.73 |
| 2025-09-30 | 2.96 |
| 2025-06-30 | 2.70 |
| 2025-03-31 | 2.39 |
| 2024-12-31 | 2.80 |
| 2024-09-30 | 2.62 |
| 2024-06-30 | 2.58 |
| 2024-03-31 | 3.31 |
| 2023-12-31 | 3.44 |
| 2023-09-30 | 3.16 |
| 2023-06-30 | 2.89 |
| 2023-03-31 | 2.55 |
| 2022-12-31 | 2.72 |
| 2022-09-30 | 2.56 |
| 2022-06-30 | 2.46 |
| 2022-03-31 | 2.40 |
| 2021-12-31 | 2.62 |
| 2021-09-30 | 2.44 |
| 2021-06-30 | 2.41 |
| 2021-03-31 | 2.26 |
| 2020-12-31 | 2.45 |
| 2020-09-30 | 2.49 |
| 2020-06-30 | 2.77 |
| 2020-03-31 | 2.74 |
| 2019-12-31 | 3.66 |
| 2019-09-30 | 0.93 |
| 2019-06-30 | 1.13 |
| 2019-03-31 | 0.95 |
| 2018-12-31 | 0.81 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
